FDA.reportPublic FDA data

PNL2 antigen IVD, antibody

Definition
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of melanocytic antigen PNL2 in a clinical specimen.
GUDID devices
8
Last updated
2025-03-07 15:57:41

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
B502BSB69150Melanoma PNL2 MmabBIO SB, INC.Concentrate, 0.1 ml2020-06-01
B502BSB69160Melanoma PNL2 MmabBIO SB, INC.Concentrate, 0.5 ml2020-06-01
B502BSB69170Melanoma PNL2 MmabBIO SB, INC.Concentrate, 1 ml2020-06-01
00841683139225PNL2 (PNL2) Mouse Monoclonal AntibodyCELL MARQUE CORPORATION365M-942022-11-14
00841683139232PNL2 (PNL2) Mouse Monoclonal AntibodyCELL MARQUE CORPORATION365M-952022-11-14
00841683139249PNL2 (PNL2) Mouse Monoclonal AntibodyCELL MARQUE CORPORATION365M-962022-11-14
00841683139256PNL2 (PNL2) Mouse Monoclonal AntibodyCELL MARQUE CORPORATION365M-972022-11-14
00841683139263PNL2 (PNL2) Mouse Monoclonal AntibodyCELL MARQUE CORPORATION365M-982022-11-14